Follow The Filings

AX Axos Financial

Axos Financial earnings company data as of 8:01 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 2.27 — —
Rev — — —

Insider trades

Open-market buys and sales by AX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AX insider trades
  • None no insider bought on the open market
  • $7.2M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Mosich Nick Director
    Sale
    $125K 1,275 shares at $98.00 1.9% of stake
    Traded Feb 17 Filed Sep 16
  2. Roque A Santi Director
    Sale
    $53K 500 shares at $105.30 6.5% of stake
    Traded Aug 5 Filed Aug 7
  3. Thomas M Constantine Insider
    Sale
    $177K 1,994 shares at $88.55 11% of stake
    Traded Jun 8 Filed Jun 9
  4. Michael James Watson Insider
    Sale
    $138K 1,653 shares at $83.77 27% of stake
    Traded May 19 Filed May 21
  5. Roque A Santi Director
    Sale
    $44K 500 shares at $87.77 6.1% of stake
    Traded May 8 Filed May 12
  6. Mosich Nick Director
    Sale
    $97K 1,000 shares at $97.00 1.2% of stake
    Traded Feb 11 Filed Feb 13
  7. Thomas M Constantine Insider
    Sale
    $326K 3,260 shares at $100.00 17% of stake
    Traded Feb 6 Filed Feb 9
  8. Derrick Walsh CFO
    Sale
    $490K 4,846 shares at $101.21 11% of stake
    Traded Feb 6 Filed Feb 6
  9. James John Court Director
    Sale
    $1.1M 11,163 shares at $101.01 26% of stake
    Traded Feb 6 Filed Feb 6
  10. Gregory Garrabrants CEO
    Sale
    $4.3M 43,294 shares at $99.10 3% of stake
    Traded Feb 4 Filed Feb 6
  11. Tamara N Bohlig Director
    Sale
    $185K 2,145 shares at $86.23 14% of stake
    Traded Dec 8, 2025 Filed Dec 10, 2025
  12. Edward James Ratinoff Director
    Sale
    $181K 2,145 shares at $84.59 4.4% of stake
    Traded Dec 5, 2025 Filed Dec 8, 2025

Also filed in the last 12 months, not counted as buying or selling: 51 sales back to the company, 51 option exercises, 5 gifts, and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
DEF 14A
DEFA14A
8-K 2.01,9.01
10-K
SCHEDULE 13G —
SCHEDULE 13G —
8-K 7.01,9.01
8-K 2.02,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 2.01,9.01
8-K 7.01,9.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
8-K 1.01,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.